کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3165957 | 1198866 | 2007 | 11 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Extranodal NK/T-cell lymphoma, nasal type Extranodal NK/T-cell lymphoma, nasal type](/preview/png/3165957.png)
SummaryExtranodal NK/T-cell lymphoma, nasal type (ENKTCL), previously known as lethal midline granuloma is a distinct clinico-pathological entity associated with Epstein-Barr virus that typically causes destruction of the midface, palatal and orbital walls. In addition, ENKTCL can involve the skin, soft tissue, testes, gastrointestinal and upper respiratory tract. ENKTCL neoplastic cells express some T-cell associated antigens, most commonly CD2 and cytoplasmic CD3ε and, in favour of an NK-cell origin, CD56. Early stage disease may respond to radiotherapy alone, however late stage disease does not respond well to any available therapies. Overall, patients with ENKTCL have a cumulative probability of survival at 5 years ranging from 37.9% to 45.3%.
Journal: Oral Oncology - Volume 43, Issue 1, January 2007, Pages 4–14